Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Bonnie L. Bassler sold 827 shares of the firm’s stock in a transaction that occurred on Tuesday, January 30th. The shares were sold at an average price of $959.00, for a total transaction of $793,093.00. Following the completion of the transaction, the director now directly owns […]
Clearstead Advisors LLC lessened its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% during the third quarter, Holdings Channel.com reports. The fund owned 462 shares of the biopharmaceutical company’s stock after selling 17 shares during the period. Clearstead Advisors LLC’s holdings in Regeneron Pharmaceuticals were worth $380,000 at the end of the […]
Hussman Strategic Advisors Inc. trimmed its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 46.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,200 shares of the biopharmaceutical company’s stock after selling 3,600 shares during […]
Hussman Strategic Advisors Inc. decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 46.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,200 shares of the biopharmaceutical company’s stock after selling 3,600 shares during the […]
Atria Investments Inc lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,150 shares of the biopharmaceutical company’s stock after selling 420 shares during the period. Atria […]